U.S. Transfusion Diagnostics Market: Immunohematology and NAT Testing--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, Emerging...

NEW YORK, Feb. 11, 2020 /PRNewswire/ --

U.S. Transfusion Diagnostics Market: Immunohematology and NAT Testing--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, Emerging Opportunities

Read the full report: https://www.reportlinker.com/p04217599/?utm_source=PRN

This new report is a strategic analysis prepared in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies.

Companies Profiled
Competitive Assessments

- Abbott
- Beckman Coulter/Danaher
- Becton Dickinson
- Biokit
- bioMerieux
- Bio-Rad
- Diagast
- DiaSorin
- Fujirebio
- Grifols
- Hologic
- Immucor
- LabCorp
- Ortho-Clinical Diagnostics
- Proteome Sciences
- Quest Diagnostics
- Quidel
- Roche
- Siemens Healthineers
- Tecan
- Thermo Fisher

Read the full report: https://www.reportlinker.com/p04217599/?utm_source=PRN

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

View original content:http://www.prnewswire.com/news-releases/us-transfusion-diagnostics-market-immunohematology-and-nat-testing--supplier-shares-and-strategies-volume-and-sales-segment-forecasts-innovative-technologies-instrumentation-review-emerging-opportunities-301002705.html

SOURCE Reportlinker